GRFS - Grifols jumps on report on takeover speculation
Grifols SA (NASDAQ:GRFS) advanced 6% on speculation that the pharmaceuticals and chemicals maker has seen some takeover interest. There's some speculation that some private equity firms are looking at Grifols (GRFS), according to a Betaville "uncooked" alert. One PE firm is said to be in the U.S, while one is in London. Not clear if the buyout firms have approached GRFS with a takeover offer. Earlier this month, Grifols ABvac40 vaccine for Alzheimer's showed safety/response in phase 2 interim data.
For further details see:
Grifols jumps on report on takeover speculation